Literature DB >> 9195092

Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus.

C Bogdan1, P Kern, E Richter, A Tannapfel, S Rüsch-Gerdes, T Kirchner, W Solbach.   

Abstract

We describe, to our knowledge, the first case of disseminated Mycobacterium genavense infection in a patient who was seronegative for human immunodeficiency virus. The patient, a 47-year-old woman, had been previously treated with immunosuppressive drugs for 9 months to control an unclassified immunologic disorder characterized by intermittent fever and inflammatory pulmonary, hepatic, and dermal infiltrates. Antemortem and postmortem examinations revealed the presence of numerous mycobacteria in the bone marrow, spleen, kidneys, and lungs; these organisms failed to grow in vitro and were identified as M. genavense by 16S rRNA gene sequencing. This case illustrates that systemic M. genavense infections are not restricted to patients with AIDS but can also occur in otherwise immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195092     DOI: 10.1086/513634

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Gamma interferon is essential for clearing Mycobacterium genavense infection.

Authors:  S Ehlers; E Richter
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Microaerophilic conditions promote growth of Mycobacterium genavense.

Authors:  L Realini; K De Ridder; J Palomino; B Hirschel; F Portaels
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 4.  Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

Review 5.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

6.  Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency.

Authors:  Blandine Rammaert; Louis-Jean Couderc; Elisabeth Rivaud; Patrick Honderlick; David Zucman; Marie-France Mamzer; Pierre Cahen; Emmanuel Bille; Marc Lecuit; Olivier Lortholary; Emilie Catherinot
Journal:  BMC Infect Dis       Date:  2011-11-05       Impact factor: 3.090

7.  Early diagnosis of disseminated Mycobacterium genavense infection.

Authors:  Victoire de Lastours; Romain Guillemain; Jean-Luc Mainardi; Agnès Aubert; Patrick Chevalier; Agnès Lefort; Isabelle Podglajen
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

8.  Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.

Authors:  M Santos; A Gil-Brusola; A Escandell; M Blanes; M Gobernado
Journal:  Patholog Res Int       Date:  2014-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.